Drug
Ryz101
Ryz101: highest development phase Phase 1/2, developed by RayzeBio, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- RayzeBio, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| RYZ101 NCT06590857 | Phase 1/2 | Metastatic Breast Cancer |
Latest
No recent events.
Follow Ryz101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.